Connect with us

Health

Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…

Published

on

Article feature image
ADVERTISEMENT

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Researchers begin work on magnetic male contraceptive – Open Access Government
Article feature image
A reversible male contraceptive, targeted to the testes with magnets – Science Daily